Literature DB >> 2434531

Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.

A K Ghosh, K C Gatter, M S Dunnill, D Y Mason.   

Abstract

A panel of seven monoclonal antiepithelial antibodies of different specificities, including anticytokeratin, human milk fat globule membrane, C, and carcinoembryonic antigen (CEA) were used with the alkaline phosphatase-antialkaline phosphatase (APAAP) immunostaining technique to determine their value in the differentiation between benign and malignant mesothelial cells and lung carcinoma in histological preparations. The anticytokeratin antibody reacted strongly with all cases of reactive mesothelium, mesothelioma, and lung carcinoma. Antibodies to human milk fat globule membrane and the Ca antigen stained mesothelioma and carcinoma and 43% of cases of reactive mesothelium. Staining for carcinoembryonic antigen was not detected in reactive mesothelium or mesothelioma, but was present in most of the lung carcinomas. CEA seemed to be the single most useful marker in distinguishing carcinoma from mesothelioma in that a positive reaction for CEA would indicate carcinoma rather than mesothelioma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434531      PMCID: PMC1140823          DOI: 10.1136/jcp.40.1.19

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions.

Authors:  M E Bramwell; A K Ghosh; W D Smith; G Wiseman; A I Spriggs; H Harris
Journal:  Cancer       Date:  1985-07-01       Impact factor: 6.860

2.  Tumour markers in serous effusions.

Authors:  A K Ghosh; A I Spriggs; M Curling
Journal:  Lancet       Date:  1984-02-11       Impact factor: 79.321

3.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

4.  Keratin proteins and carcinoembryonic antigen in lung carcinoma: an immunoperoxidase study of fifty-four cases, with ultrastructural correlations.

Authors:  J W Said; G Nash; G Tepper; S Banks-Schlegel
Journal:  Hum Pathol       Date:  1983-01       Impact factor: 3.466

5.  Immunohistological study of malignant diffuse mesotheliomas of the pleura.

Authors:  H Loosli; J Hurlimann
Journal:  Histopathology       Date:  1984-09       Impact factor: 5.087

6.  Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.

Authors:  R J Marshall; A Herbert; S G Braye; D B Jones
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

7.  Reactivity pattern of a monoclonal antikeratin antibody (KL1).

Authors:  J Viac; A Reano; J Brochier; M J Staquet; J Thivolet
Journal:  J Invest Dermatol       Date:  1983-10       Impact factor: 8.551

8.  Keratin in human lung tumors. Patterns of localization of different-molecular-weight keratin proteins.

Authors:  J W Said; G Nash; S Banks-Schlegel; A F Sassoon; S Murakami; I P Shintaku
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

9.  Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining.

Authors:  W S Kwee; R W Veldhuizen; R P Golding; H Mullink; J Stam; R Donner; M E Boon
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

10.  Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.

Authors:  J Holden; A Churg
Journal:  Am J Surg Pathol       Date:  1984-04       Impact factor: 6.394

View more
  15 in total

1.  Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions.

Authors:  A Linari; G Bussolati
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

2.  Immunocytochemical investigation of the tissue of origin of two lung cancer cell lines.

Authors:  M R Daniel; H E Burnett
Journal:  Int J Exp Pathol       Date:  1991-08       Impact factor: 1.925

Review 3.  Molecular biology and respiratory disease. 3. Evaluation of nucleolar organiser regions in pulmonary pathology.

Authors:  M J Egan; J Crocker
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

4.  Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.

Authors:  T Kawai; S D Greenberg; L D Truong; C A Mattioli; M Klima; J L Titus
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

5.  Immunohistochemistry in district general hospitals in England and Wales.

Authors:  P A Hall; P Domizio; G Slavin; D A Levison
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

6.  Use of antimesothelial cell antibody and computer assisted quantitative analysis for distinguishing between reactive and neoplastic serosal tissues.

Authors:  A Donna; P G Betta; F Robutti
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

7.  Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.

Authors:  A K Ghosh; E B Butler
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

8.  Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

Authors:  U Latza; G Niedobitek; R Schwarting; H Nekarda; H Stein
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

9.  Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings.

Authors:  H Moch; M Oberholzer; P Dalquen; W Wegmann; F Gudat
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.

Authors:  C J O'Hara; J M Corson; G S Pinkus; R A Stahel
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.